NEXOBRID

This brand name is authorized in Austria, Estonia, Spain, Finland, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug NEXOBRID contains one active pharmaceutical ingredient (API):

1 Partially purified bromelain UNII KVZ6B40N8U - ANANAS COMOSUS WHOLE

Read about

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D03BA03		D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03B Enzymes → D03BA Proteolytic enzymes
Discover more medicines within D03BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1603583, 1603594
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 112803001, 112803002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 172192
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 335155, 368656
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8711, 8712
Country: IT	Agenzia del Farmaco	Identifier(s): 042539015, 042539027
Country: JP	医薬品医療機器総合機構	Identifier(s): 26997A5Q1025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1068856, 1068857
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100069129, 100295794
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W61294001, W61476001